(OMC) Omnicom - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6819191064
Stock: Advertising, Marketing, Communications, Branding, Data
Total Rating 19
Risk 67
Buy Signal -0.53
| Risk 5d forecast | |
|---|---|
| Volatility | 33.9% |
| Relative Tail Risk | -6.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -16.76 |
| Character TTM | |
|---|---|
| Beta | 0.775 |
| Beta Downside | 0.383 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.29% |
| CAGR/Max DD | 0.02 |
EPS (Earnings per Share)
Revenue
Description: OMC Omnicom March 04, 2026
Omnicom Group Inc. (OMC) is a global advertising and marketing services company. The company provides a broad spectrum of services, including traditional advertising, precision marketing, public relations, and healthcare communications. This business model relies on client relationships across diverse industries.
OMCs offerings encompass digital transformation, e-commerce optimization, and data analytics, reflecting the evolving landscape of the advertising sector. The company maintains a global presence, operating in North and Latin America, Europe, the Middle East, Africa, and Asia Pacific. Further research on platforms like ValueRay can provide deeper insights into OMCs operational specifics.
Headlines to watch out for
- Global advertising spend directly impacts Omnicoms revenue growth
- Digital transformation services drive new client acquisitions
- Economic downturns reduce marketing budgets for clients
- Talent acquisition and retention costs affect profitability
- Regulatory changes in data privacy impact advertising strategies
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -54.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.25 > 1.0 |
| NWC/Revenue: -12.00% < 20% (prev -0.49%; Δ -11.51% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.94b > Net Income -54.5m |
| Net Debt (5.90b) to EBITDA (825.3m): 7.15 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (233.8m) vs 12m ago 17.84% < -2% |
| Gross Margin: 17.28% > 18% (prev 0.17%; Δ 1710 % > 0.5%) |
| Asset Turnover: 41.11% > 50% (prev 52.97%; Δ -11.86% > 0%) |
| Interest Coverage Ratio: 2.08 > 6 (EBITDA TTM 825.3m / Interest Expense TTM 263.4m) |
Altman Z'' 0.73
| A: -0.04 (Total Current Assets 27.47b - Total Current Liabilities 29.54b) / Total Assets 54.42b |
| B: 0.20 (Retained Earnings 10.78b / Total Assets 54.42b) |
| C: 0.01 (EBIT TTM 548.6m / Avg Total Assets 42.02b) |
| D: 0.23 (Book Value of Equity 9.58b / Total Liabilities 41.36b) |
| Altman-Z'' Score: 0.73 = B |
Beneish M -2.29
| DSRI: 1.75 (Receivables 17.81b/9.24b, Revenue 17.27b/15.69b) |
| GMI: 1.01 (GM 17.28% / 17.47%) |
| AQI: 1.16 (AQ_t 0.45 / AQ_t-1 0.39) |
| SGI: 1.10 (Revenue 17.27b / 15.69b) |
| TATA: -0.05 (NI -54.5m - CFO 2.94b) / TA 54.42b) |
| Beneish M-Score: -2.29 (Cap -4..+1) = BBB |
What is the price of OMC shares?
As of March 11, 2026, the stock is trading at USD 80.98 with a total of 4,638,444 shares traded.
Over the past week, the price has changed by -4.30%, over one month by +10.84%, over three months by +5.63% and over the past year by -1.72%.
Over the past week, the price has changed by -4.30%, over one month by +10.84%, over three months by +5.63% and over the past year by -1.72%.
Is OMC a buy, sell or hold?
Omnicom has received a consensus analysts rating of 3.91.
Therefore, it is recommended to buy OMC.
- StrongBuy: 3
- Buy: 5
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the OMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.9 | 24.6% |
| Analysts Target Price | 100.9 | 24.6% |
OMC Fundamental Data Overview March 10, 2026
P/E Forward = 9.1324
P/S = 1.547
P/B = 2.1881
P/EG = 17.2307
Revenue TTM = 17.27b USD
EBIT TTM = 548.6m USD
EBITDA TTM = 825.3m USD
Long Term Debt = 7.66b USD (from longTermDebt, last quarter)
Short Term Debt = 1.89b USD (from shortTermDebt, last quarter)
Debt = 12.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.90b USD (from netDebt column, last quarter)
Enterprise Value = 32.62b USD (26.72b + Debt 12.78b - CCE 6.88b)
Interest Coverage Ratio = 2.08 (Ebit TTM 548.6m / Interest Expense TTM 263.4m)
EV/FCF = 11.70x (Enterprise Value 32.62b / FCF TTM 2.79b)
FCF Yield = 8.55% (FCF TTM 2.79b / Enterprise Value 32.62b)
FCF Margin = 16.14% (FCF TTM 2.79b / Revenue TTM 17.27b)
Net Margin = -0.32% (Net Income TTM -54.5m / Revenue TTM 17.27b)
Gross Margin = 17.28% ((Revenue TTM 17.27b - Cost of Revenue TTM 14.29b) / Revenue TTM)
Gross Margin QoQ = 17.79% (prev 18.14%)
Tobins Q-Ratio = 0.60 (Enterprise Value 32.62b / Total Assets 54.42b)
Interest Expense / Debt = 0.64% (Interest Expense 81.3m / Debt 12.78b)
Taxrate = 21.0% (US default 21%)
NOPAT = 433.4m (EBIT 548.6m * (1 - 21.00%))
Current Ratio = 0.93 (Total Current Assets 27.47b / Total Current Liabilities 29.54b)
Debt / Equity = 1.06 (Debt 12.78b / totalStockholderEquity, last quarter 12.05b)
Debt / EBITDA = 7.15 (Net Debt 5.90b / EBITDA 825.3m)
Debt / FCF = 2.12 (Net Debt 5.90b / FCF TTM 2.79b)
Total Stockholder Equity = 6.38b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.13% (Net Income -54.5m / Total Assets 54.42b)
RoE = -0.85% (Net Income TTM -54.5m / Total Stockholder Equity 6.38b)
RoCE = 3.91% (EBIT 548.6m / Capital Employed (Equity 6.38b + L.T.Debt 7.66b))
RoIC = 3.25% (NOPAT 433.4m / Invested Capital 13.34b)
WACC = 6.09% (E(26.72b)/V(39.50b) * Re(8.77%) + D(12.78b)/V(39.50b) * Rd(0.64%) * (1-Tc(0.21)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.26%
[DCF] Terminal Value 87.73% ; FCFF base≈2.31b ; Y1≈2.85b ; Y5≈4.85b
[DCF] Fair Price = 407.5 (EV 132.36b - Net Debt 5.90b = Equity 126.46b / Shares 310.3m; r=6.09% [WACC]; 5y FCF grow 24.94% → 2.90% )
EPS Correlation: 68.42 | EPS CAGR: 18.05% | SUE: -0.82 | # QB: 0
Revenue Correlation: 72.21 | Revenue CAGR: 13.75% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.77 | Chg7d=+0.350 | Chg30d=+0.363 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=10.74 | Chg7d=-0.396 | Chg30d=+0.769 | Revisions Net=+5 | Growth EPS=+24.1% | Growth Revenue=+45.3%
EPS next Year (2027-12-31): EPS=12.61 | Chg7d=-0.126 | Chg30d=+0.933 | Revisions Net=+6 | Growth EPS=+17.5% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
P/S = 1.547
P/B = 2.1881
P/EG = 17.2307
Revenue TTM = 17.27b USD
EBIT TTM = 548.6m USD
EBITDA TTM = 825.3m USD
Long Term Debt = 7.66b USD (from longTermDebt, last quarter)
Short Term Debt = 1.89b USD (from shortTermDebt, last quarter)
Debt = 12.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.90b USD (from netDebt column, last quarter)
Enterprise Value = 32.62b USD (26.72b + Debt 12.78b - CCE 6.88b)
Interest Coverage Ratio = 2.08 (Ebit TTM 548.6m / Interest Expense TTM 263.4m)
EV/FCF = 11.70x (Enterprise Value 32.62b / FCF TTM 2.79b)
FCF Yield = 8.55% (FCF TTM 2.79b / Enterprise Value 32.62b)
FCF Margin = 16.14% (FCF TTM 2.79b / Revenue TTM 17.27b)
Net Margin = -0.32% (Net Income TTM -54.5m / Revenue TTM 17.27b)
Gross Margin = 17.28% ((Revenue TTM 17.27b - Cost of Revenue TTM 14.29b) / Revenue TTM)
Gross Margin QoQ = 17.79% (prev 18.14%)
Tobins Q-Ratio = 0.60 (Enterprise Value 32.62b / Total Assets 54.42b)
Interest Expense / Debt = 0.64% (Interest Expense 81.3m / Debt 12.78b)
Taxrate = 21.0% (US default 21%)
NOPAT = 433.4m (EBIT 548.6m * (1 - 21.00%))
Current Ratio = 0.93 (Total Current Assets 27.47b / Total Current Liabilities 29.54b)
Debt / Equity = 1.06 (Debt 12.78b / totalStockholderEquity, last quarter 12.05b)
Debt / EBITDA = 7.15 (Net Debt 5.90b / EBITDA 825.3m)
Debt / FCF = 2.12 (Net Debt 5.90b / FCF TTM 2.79b)
Total Stockholder Equity = 6.38b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.13% (Net Income -54.5m / Total Assets 54.42b)
RoE = -0.85% (Net Income TTM -54.5m / Total Stockholder Equity 6.38b)
RoCE = 3.91% (EBIT 548.6m / Capital Employed (Equity 6.38b + L.T.Debt 7.66b))
RoIC = 3.25% (NOPAT 433.4m / Invested Capital 13.34b)
WACC = 6.09% (E(26.72b)/V(39.50b) * Re(8.77%) + D(12.78b)/V(39.50b) * Rd(0.64%) * (1-Tc(0.21)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.26%
[DCF] Terminal Value 87.73% ; FCFF base≈2.31b ; Y1≈2.85b ; Y5≈4.85b
[DCF] Fair Price = 407.5 (EV 132.36b - Net Debt 5.90b = Equity 126.46b / Shares 310.3m; r=6.09% [WACC]; 5y FCF grow 24.94% → 2.90% )
EPS Correlation: 68.42 | EPS CAGR: 18.05% | SUE: -0.82 | # QB: 0
Revenue Correlation: 72.21 | Revenue CAGR: 13.75% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.77 | Chg7d=+0.350 | Chg30d=+0.363 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=10.74 | Chg7d=-0.396 | Chg30d=+0.769 | Revisions Net=+5 | Growth EPS=+24.1% | Growth Revenue=+45.3%
EPS next Year (2027-12-31): EPS=12.61 | Chg7d=-0.126 | Chg30d=+0.933 | Revisions Net=+6 | Growth EPS=+17.5% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)